Alcohol once again leading cause for drug treatment As more patients seek out alcohol and other drug treatment, GPs say with greater funding many more could be supported in general practice.
New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
New research highlights rural diabetes gaps It found rural Aboriginal and Torres Strait Islander patients with diabetes face greater health risks, urging action on equitable care.
‘Underestimated’: Serious health impact of flooding revealed A study found communities face a 26% increased risk of serious disease after a flood, with the ongoing strain on healthcare lasting up to 210 days.
Drug summit report reveals points for reform Building a better trained workforce is among its recommendations, with GPs calling for recognition of their ‘life-saving role’.
Sixty-day scripts slow to find favour: Study With a significantly lower-than-expected uptake, an RACGP expert says this could be caused by software impediments, complexity over medication eligibility, and patient views.
‘Stopping antidepressants or not?’ New research says collaborative primary care planning between GPs and patients is key to decisions around prescribing and cessation.
What is stopping kids getting a flu vaccination? A survey of Australian parents has revealed the practical difficulties and acceptance barriers leading to falling vaccination rates.
RACGP vows to support a healthcare system free from racism Reiterating its ‘zero tolerance’ approach, the college’s updated position pledges to drive change across healthcare.
In Practice: 2025 flu vaccines arriving early April Delivery of Sanofi’s VaxiGrip Tetra vaccine for this year’s influenza season is expected to arrive within weeks, the DoHAC confirmed.